- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT05296343
Guidelines for Parental Involvement in the Care of Suicidal Youth (S-Urg-Quali)
Developing Guidelines for Parental Involvement in the Emergency Care of Suicidal Adolescents and Young Adults: a Qualitative Study
Parents occupy a central place in the emergency care of suicidal adolescents and young adults. However, from 15 to 25yo, three different administrative situations exist in France:
- <16yo: admission to a child ED by a team trained to receive the youngest patients.
- 16-18yo: admission to an adult ED by team devoted to adult care, no exit without parents' authorization.
- >18yo: admission to an adult ED by team.
Laying on qualitative observational protocol and a Delphi approach, this study will explore the perspective of adolescents and young adults following a suicidal attempt, the perspective of their parents, and the perspective of their healthcare professionals to build guidelines for parental involvement in care of suicidal youths.
Visão geral do estudo
Status
Condições
Descrição detalhada
Suicide is the second leading cause of death among 15-25 year olds, with the highest rate of hospitalization for SC of any age group. The psychopathology of suicidal behavior in adolescents and young adults (AYA) is homogeneous: risk factors, precipitating factors, representations. Parents occupy a central place in care. They are i) involved in the care decision; ii) actively involved in care; and ii) a source of motivation for trust and adherence to care.
However, if the psychopathology of suicidal crisis is homogeneous, the transition between pediatric and adult care implies very different management in the emergency department (ED). In France, three situations can be described:
- <16yo: admission to a child ED by a team trained to receive the youngest patients.
- 16-18yo: admission to an adult ED by team devoted to adult care, no exit without parents' authorization.
- >18yo: admission to an adult ED by team devoted to adult care, no right to contact the parents in case of patient opposition.
- Before 16 years of age: admission to the children's UAS, care by a team trained to receive the youngest patients.
- 16-18 years: admission to the adult UAS, care by adult professionals, clinical and legal particularities of care for minors.
- After 18 years old: admission to adult UAS, legal constraints of the adult care setting.
The objectives of this qualitative observational study is to build guidelines for the involvement of the parents in the care in these three situations.
The study will include adolescents and young adults from the three situations, their parents and the professionals who take care of them. Individual semi-structured interviews will be organized to collect their experiences. Qualitative analyses will be conduct, following Interpretative Phenomenological Analysis. A pre-approved guideline will be construct and a Delphi approach will be conducted to approved the final version of the guideline.
Tipo de estudo
Inscrição (Antecipado)
Contactos e Locais
Locais de estudo
-
-
-
Clermont-Ferrand, França, 63000
- CHU de Clermont-Ferrand
-
Investigador principal:
- Jonathan Lachal
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Método de amostragem
População do estudo
Descrição
Inclusion Criteria:
Adolescents and Young adults
- Admitted to an Emergency Department (ED) following a suicidal act or considered as such by the medical team
Parents
- Parents of the included youths >18y
Healthcare professionals
- >18y
- Working in ED
- Usually taking care of suicidal youths
All the participants
- French speaking
- Affiliation to a social security regime
- Participation agreement
Exclusion Criteria:
All the participants
- Present an acute somatic or psychiatric disease which may hinder the well organization of the interview
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
Coortes e Intervenções
Grupo / Coorte |
|---|
|
Adolescents and young adults
Boys and girls from 15 to 25 years old admitted to an Emergency Department (ED) following a suicidal act or considered as such by the medical team
|
|
Parents
One or the two parents of the included adolescents and young adults
|
|
Healthcare professionals
Professionals working in one emergency departments of the inclusion centers and who usually take care of suicidal adolescents and young adults
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Developing guidelines defining the role of parents in the medical decision and the care of the youths
Prazo: Day 1
|
Thematic framework summarizing the perspectives of three groups of participants.
|
Day 1
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Describing each context of care
Prazo: Day 1
|
Qualitative description of each of the three context of care (<16y, 16-18y, >18y)
|
Day 1
|
|
Describing expectations from each group
Prazo: Day 1
|
Qualitative description of each of the three participant groups (adolescents and young adults, parents, professionals)
|
Day 1
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Jonathan Lachal, University Hospital, Clermont-Ferrand
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Antecipado)
Conclusão Primária (Antecipado)
Conclusão do estudo (Antecipado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- AOI 2021 LACHAL
- 2021-A03244-37 (Outro identificador: ANSM)
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .